Search Results - "Rousseau, Dennis L."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma by Gannon, Christopher J., Rousseau, Dennis L., Ross, Merrick I., Johnson, Marcella M., Lee, Jeffrey E., Mansfield, Paul F., Cormier, Janice N., Prieto, Victor G., Gershenwald, Jeffrey E.

    Published in Cancer (01-12-2006)
    “…BACKGROUND. Sentinel lymph node (SLN) status is the most important prognostic factor with respect to the survival of patients with primary cutaneous melanoma…”
    Get full text
    Journal Article
  2. 2

    Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients by Rousseau, Jr, Dennis L, Ross, Merrick I, Johnson, Marcella M, Prieto, Victor G, Lee, Jeffrey E, Mansfield, Paul F, Gershenwald, Jeffrey E

    Published in Annals of surgical oncology (01-06-2003)
    “…The American Joint Committee on Cancer (AJCC) has recently modified staging criteria for primary melanoma patients and recommends sentinel lymph node (SLN)…”
    Get full text
    Journal Article
  3. 3

    Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal by Thaker, Premal H., Yokoi, Kenji, Jennings, Nicholas B., Li, Yang, Rebhun, Robert B., Rousseau Jr, Dennis L., Fan, Dominic, Sood, Anil K.

    Published in Cancer biology & therapy (01-07-2005)
    “…Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter, and GABA receptors have been recently detected on epithelial colon cancer cells. Nembutal…”
    Get full text
    Journal Article
  4. 4

    Neoplastic conversion of human colon smooth muscle cells: No requirement for telomerase by Liang, Sitai, Kahlenberg, Morton S., Rousseau Jr, Dennis L., Hornsby, Peter J.

    Published in Molecular carcinogenesis (01-06-2008)
    “…The role of telomerase as an essential requirement for the neoplastic conversion of human cells has been controversial. In the model of conversion of normal…”
    Get full text
    Journal Article
  5. 5

    HER‐2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma by Learn, Peter A., Yeh, I‐Tien, McNutt, Michelle, Chisholm, Gary B., Pollock, Brad H., Rousseau, Dennis L., Sharkey, Frances E., Cruz, Anatolio B., Kahlenberg, Morton S.

    Published in Cancer (01-06-2005)
    “…BACKGROUND The use of biologic markers to predict response to neoadjuvant chemotherapy may permit tailoring regimens to achieve maximal tumor response. Taxanes…”
    Get full text
    Journal Article
  6. 6

    Squamous cell carcinoma of the anal canal by Rousseau, Dennis L., Thomas, Charles R., Petrelli, Nicholas J., Kahlenberg, Morton S.

    Published in Surgical oncology (01-11-2005)
    “…Squamous cell carcinoma (SCC) of the anal canal is a rare condition with increasing incidence rates in the United States population in the past several…”
    Get full text
    Journal Article
  7. 7

    The new staging system for cutaneous melanoma in the era of lymphatic mapping by Rousseau, Dennis L, Gershenwald, Jeffrey E

    Published in Seminars in oncology (01-06-2004)
    “…In 2002, the American Joint Committee on Cancer (AJCC) revised the staging system for cutaneous melanoma on the basis of a survival analysis of important…”
    Get full text
    Journal Article
  8. 8

    Safety and efficacy of metallic stents in the management of colorectal obstruction by Stefanidis, Dimitrios, Brown, Ken, Nazario, Hector, Trevino, Hector H, Ferral, Hector, Brady, 3rd, Charles E, Gross, Glenn W, Postoak, Darren W, Chadhury, Riaz, Rousseau, Jr, Dennis L, Kahlenberg, Morton S

    “…The use of self-expandable metallic stents in the management of obstructing colorectal cancer has been described with increasing frequency in the literature…”
    Get full text
    Journal Article
  9. 9

    Overview of anal cancer for the surgeon by Rousseau, Jr, Dennis L, Petrelli, Nicholas J, Kahlenberg, Morton S

    Published in Surgical oncology clinics of North America (01-04-2004)
    “…Cancers of the anal canal represent a diverse group of pathology and require a multidisciplinary approach for treatment. For the most common anal canal cancer,…”
    Get more information
    Journal Article
  10. 10

    Liver imaging. A surgeon's perspective by Vauthey, J Nicolas, Rousseau, Jr, Dennis L

    Published in Clinics in liver disease (01-02-2002)
    “…Advances in the diagnosis and treatment of liver lesions have improved therapy for a broad range of clinical conditions, many of which could not be effectively…”
    Get more information
    Journal Article
  11. 11

    Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival by Stefanidis, Dimitrios, Pollock, Brad H, Miranda, Jennifer, Wong, Adrian, Sharkey, Francis E, Rousseau, Dennis L, Thomas, Jr, Charles R, Kahlenberg, Morton S

    Published in American journal of clinical oncology (01-04-2006)
    “…While colorectal cancer (CRC) incidence and mortality rates have declined slightly over the past decade, there remain marked differences by ethnicity. Our aim…”
    Get full text
    Journal Article
  12. 12

    The interaction of epidermal growth factor with its receptor in A431 cell membranes: a stopped-flow fluorescence anisotropy study by Rousseau, Dennis L, Staros, James V, Beechem, Joseph M

    Published in Biochemistry (Easton) (01-11-1995)
    “…We describe a quantitative examination of the interaction of epidermal growth factor (EGF) with the EGF receptor using A431 cell membrane vesicles as a…”
    Get full text
    Journal Article
  13. 13

    Co-expression of ferrochelatase allows for complete heme incorporation into recombinant proteins produced in E. coli by Sudhamsu, Jawahar, Kabir, Mariam, Airola, Michael V., Patel, Bhumit A., Yeh, Syun-Ru, Rousseau, Denis L., Crane, Brian R.

    Published in Protein expression and purification (01-09-2010)
    “…Over-expression of heme binding proteins in Escherichia coli often results in sub-optimal heme incorporation and the amount of heme-bound protein produced…”
    Get full text
    Journal Article
  14. 14
  15. 15